Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis.

Hameed O, Adams AL, Baker AC, Balmer NE, Bell WC, Burford HN, Chhieng DC, Jhala NC, Klein MJ, Winokur T
Am J Clin Pathol. 2008 130 (3): 425-7

PMID: 18701416 · DOI:10.1309/KETM3HANLUQHW7YV

MeSH Terms (7)

Breast Neoplasms Female Humans Immunohistochemistry Observer Variation Receptor, ErbB-2 Reproducibility of Results

Connections (1)

This publication is referenced by other Labnodes entities:

Links